S. Thomson

发表

Targeting a Polyepitope Protein Incorporating Multiple Class II-Restricted Viral Epitopes to the Secretory/Endocytic Pathway Facilitates Immune Recognition by CD4+ Cytotoxic T Lymphocytes: a Novel Approach to Vaccine Design

Scott R. Burrows, Scott A. Thomson, Rajiv Khanna, 1998, Journal of Virology.

Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.

D. Moss, A. Suhrbier, L. Brown, 1998, Journal of immunology.

Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.

X. Mo, P. Doherty, D. Moss, 1996, Journal of immunology.

Immunogenicity of a Human Immunodeficiency Virus (HIV) Polytope Vaccine Containing Multiple HLA A2 HIV CD8+ Cytotoxic T-Cell Epitopes

J. Gardner, F. Lemonnier, A. Suhrbier, 1999, Journal of Virology.

Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.

S. Thomson, W. Britton, N. West, 2011, Vaccine.

Targeting of EBNA1 for Rapid Intracellular Degradation Overrides the Inhibitory Effects of the Gly-Ala Repeat Domain and Restores CD8+ T Cell Recognition*

S. Burrows, R. Khanna, D. Moss, 2001, The Journal of Biological Chemistry.

Novel Approach to the Formulation of an Epstein-Barr Virus Antigen-Based Nasopharyngeal Carcinoma Vaccine

D. Moss, S. Thomson, P. Crooks, 2009, Journal of Virology.

HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogens.

A. Gould, S. Thomson, J. Kattenbelt, 2010, Virology.

HBsAg-vectored DNA vaccines elicit concomitant protective responses to multiple CTL epitopes relevant in human disease

A. Gould, S. Thomson, J. Kattenbelt, 2008 .

Immunogenicity of a Human Immunodeficiency Virus (HIV) Polytope Vaccine Containing Multiple HLA A2 HIV CD8 1

F. Lemonnier, A. Suhrbier, S. Thomson, 1999 .

Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.

A. Ramsay, S. Thomson, B. Coupar, 2006, Vaccine.

Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.

D. Montefiori, S. Kent, M. Law, 2005, Vaccine.

Combinations of IFN-γand IL-4 induce distinct profiles of dendritic cell-associated immunoregulatory properties

S. Thomson, J. Banyer, N. H. Hamilton, 2003, Genes and Immunity.

IFN‐γ Regulates Murine Interferon‐Inducible T Cell Alpha Chemokine (I‐TAC) Expression in Dendritic Cell Lines and during Experimental Autoimmune Encephalomyelitis (EAE)

A. Ramsay, S. Thomson, J. Banyer, 2002 .

IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).

A. Ramsay, S. Thomson, J. Banyer, 2002, Scandinavian journal of immunology.

Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.

S. Burrows, R. Khanna, D. Moss, 1995, Virology.

The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

T. Schulz, J. McKeating, S. Thomson, 1991, AIDS research and human retroviruses.

Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection

A. Gould, S. Thomson, J. Kattenbelt, 2010, Cancer Gene Therapy.

Comparative Efficacy of Subtype AE Simian-Human Immunodeficiency Virus Priming and Boosting Vaccines in Pigtail Macaques

C. Fernandez, M. Davenport, S. Kent, 2006, Journal of Virology.

Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials.

D. Purcell, S. Kent, S. Thomson, 2006, Vaccine.

A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1

M. Bebbington, D. Cooper, D. Purcell, 2006, AIDS (London).

Prime-boost strategies in DNA vaccines.

S. Kent, J. Pamungkas, S. Thomson, 2006, Methods in molecular medicine.

Efficacy of DNA and Fowlpox Virus Priming/Boosting Vaccines for Simian/Human Immunodeficiency Virus

D. Montefiori, S. Kent, M. Law, 2004, Journal of Virology.

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity

S. Kent, A. Suhrbier, A. Ramsay, 1999, Immunological reviews.

Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNgamma or IL-12.

D. Cooper, D. Purcell, S. Kent, 2004, Vaccine.

Comparison of whole gene and whole virus scrambled antigen approaches for DNA prime and fowlpox virus boost HIV type 1 vaccine regimens in macaques.

S. Kent, J. Pamungkas, S. Thomson, 2005, AIDS research and human retroviruses.

Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques.

J. Reece, C. Fernandez, S. Kent, 2005, Vaccine.

Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell‐mediated immune recognition of human melanoma cells

R. Tampé, P. van Endert, L. Cooper, 1998, International journal of cancer.

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.

D J Moss, R Khanna, S. Burrows, 1995, Proceedings of the National Academy of Sciences of the United States of America.

A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour

Ian Ramshaw, S. Thomson, R. Tindle, 2005, Cancer Immunology, Immunotherapy.

Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma.

L. Cooper, R. Khanna, S. Thomson, 2003, Blood.

Induction of Therapeutic T-Cell Responses to Subdominant Tumor-associated Viral Oncogene after Immunization with Replication-incompetent Polyepitope Adenovirus Vaccine

L. Cooper, R. Khanna, D. Moss, 2004, Cancer Research.

Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population.

Andrew Brooks, A. Ramsay, S. Thomson, 2002, International immunology.

Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs.

P. Cresswell, S. Burrows, L. Cooper, 1997, Journal of immunology.

Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.

J. Moore, R. Weiss, J. McKeating, 1990, AIDS.

Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use.

S. Kent, S. Thomson, I. Ramshaw, 2005, Vaccine.

A Recombinant Vaccinia Virus Encoding the Interferon‐Inducible T‐Cell Alpha Chemoattractant is Attenuated In Vivo

S. Thomson, J. Banyer, I. Ramshaw, 2004, Scandinavian journal of immunology.

Immunogenicity of an HIV polytope vaccine containing multiple HLA-A2 HIV CD8+ cytotoxic T cell epitopes

F. Lemonnier, A. Suhrbier, S. Thomson, 1999 .

IFN‐γ Regulates Murine Interferon‐Inducible T Cell Alpha Chemokine (I‐TAC) Expression in Dendritic Cell Lines and during Experimental Autoimmune Encephalomyelitis (EAE)

E. Thorsby, K. Lundin, A. Ramsay, 2002 .